Publication | Closed Access

Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway

Metabolic SyndromeLkb1/ampk PathwayCardiomyopathyBiochemistryMedicineLipid PeroxidationDiabetesPhysiologyType 2Diabetic MiceMetabolic RemodelingMetabolismPharmacologyOxidative StressHealth Sciences